Correlation Between SAB Biotherapeutics and Soleno Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Soleno Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Soleno Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Soleno Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Soleno is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Soleno Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Soleno Therapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 8.05 times more return on investment than Soleno Therapeutics. However, SAB Biotherapeutics is 8.05 times more volatile than Soleno Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.13 per unit of risk. If you would invest 6.20 in SAB Biotherapeutics on November 2, 2024 and sell it today you would lose (3.05) from holding SAB Biotherapeutics or give up 49.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Soleno Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Soleno Therapeutics |
SAB Biotherapeutics and Soleno Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Soleno Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Soleno Therapeutics vs. Annexon | Soleno Therapeutics vs. Bolt Biotherapeutics | Soleno Therapeutics vs. Lyra Therapeutics | Soleno Therapeutics vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |